A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)

Launched by MERCK SHARP & DOHME LLC · Feb 9, 2011

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of vaginal candidiasis
• • No Trichomonas vaginalis or any other protozoa
• • No clinical evidences of infection by Neisseria gonorrhoeae, Chlamydia trachomatis, or viral infections
• Exclusion Criteria:
• • Known sensitivity to the formula components
• • Pregnant or nursing patients
• • Any gynecological condition contraindicating the use of vaginal ovule or cream.
• • Use of any other local or systemic bactericidal, anti-protozoa or antifungal agent within the 2 weeks prior to the study start or during it
• • Presence of other sexually transmitted diseases (except from Candidal vaginitis).
• • History of recurrent candidiasis (≥4 episodes per year)
• • Use of intra-uterine device, spermicides, or diaphragms
• • Has metabolic or immune disorder
• • Has abnormal uterine bleeding